Head-to-head · Cost-Efficiency Index
Navio MD vs Maximus
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Navio MD
Shoppers who want compounded tirzepatide with a brand-name fallback path on the same platform, 48 states.
Visit Navio MDMaximus
People who want compounded tirzepatide at a flat price across doses and are willing to prepay at least two months, or who want brand-name pens and tablets in the same account.
Visit MaximusThe verdict
Navio MD and Maximus tie on the Cost-Efficiency Index at 73/100, so neither wins outright on the numbers, so choose on fit. Navio MD: Shoppers who want compounded tirzepatide with a brand-name fallback path on the same platform, 48 states. Maximus: People who want compounded tirzepatide at a flat price across doses and are willing to prepay at least two months, or who want brand-name pens and tablets in the same account.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Navio MD.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Navio MD | Maximus |
|---|---|---|
| Cost-Efficiency Index | 73/100 | 73/100 |
| Semaglutide / mo | $345/moBrand Ozempic | Not offered |
| Tirzepatide / mo | $189/moStarting dose, compounded | $249.99/mo2-month plan, billed up front, compounded |
| Semaglutide / yr (modeled) | $4,140 | — |
| Tirzepatide / yr (modeled) | $2,268 | $2,988 |
| Coverage | 48 states | 47 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Yes | Yes |
| Rank here | #87 | #92 |
Navio MD
73/100Where the value is
- LegitScript certified with board-certified providers claimed
- Both compounded and brand-name options on one platform
- 48-state coverage with the two exclusions (AL, MS) explicitly disclosed rather than hidden
The tradeoffs
- No compounded semaglutide offered — only brand-name Ozempic for that molecule, at a much higher price than compounded competitors
- All prices are 'as low as' floors; the exact dose tied to each starting price is not published
Maximus
73/100Where the value is
- Its pricing FAQ lists every plan length: $249.99 a month on 2 months, $219.99 on 4, $199.99 on 6 and $149.99 on 12, with no separate first-month price
- One flat rate covers every dose tier, with no membership fee and free shipping
- Also offers brand-name Wegovy, Ozempic, Zepbound and Mounjaro pens plus the Wegovy and Foundayo tablets
The tradeoffs
- There is no month-to-month tirzepatide plan: the shortest is two months, billed up front, and plans renew automatically at the same term
- No compounded semaglutide option
Regulatory note: the FDA issued a warning letter to Maximus Health, Inc. dba Maximus in June 2026. We still list and link to Maximus; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.